IZBA

This brand name is authorized in Austria, Canada, Estonia, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania

Active ingredients

The drug IZBA contains one active pharmaceutical ingredient (API):

1 Travoprost UNII WJ68R08KX9 - TRAVOPROST

Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. Read about Travoprost

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE04	Travoprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02457997
Country: EE	Ravimiamet	Identifier(s): 1642441, 1642452
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 427321, 439719
Country: FR	Base de données publique des médicaments	Identifier(s): 69331180
Country: IT	Agenzia del Farmaco	Identifier(s): 043310010, 043310022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1072845, 1072846
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100314340
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64506001